Challenges with biomarkers in cancer drug discovery and development

Ecaterina Ileana Dumbrava¹, Funda Meric-Bernstam^{1

2

3}, Timothy A Yap^{1

2

4

5}

Affiliations

¹ a Department of Investigational Cancer Therapeutics (Phase I Program) , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
² b Khalifa Institute for Personalized Cancer Therapy , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
³ c Department of Breast Surgical Oncology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
⁴ d Institute for Applied Cancer Science , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
⁵ e Department of Thoracic/Head and Neck Medical Oncology.

Editorial

Ecaterina Ileana Dumbrava et al. Expert Opin Drug Discov. 2018 Aug.

. 2018 Aug;13(8):685-690.

doi: 10.1080/17460441.2018.1479740. Epub 2018 May 24.

Ecaterina Ileana Dumbrava¹, Funda Meric-Bernstam^{1

2

3}, Timothy A Yap^{1

2

4

5}

¹ a Department of Investigational Cancer Therapeutics (Phase I Program) , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
² b Khalifa Institute for Personalized Cancer Therapy , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
³ c Department of Breast Surgical Oncology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
⁴ d Institute for Applied Cancer Science , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
⁵ e Department of Thoracic/Head and Neck Medical Oncology.

No abstract available

Publication types